Concepedia

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

Albert C. Ludolph, Joachim Schuster, Johannes Dorst, Luc Dupuis, Jens Dreyhaupt, Jochen H. Weishaupt, Jan Kassubek, Ulrike Weiland, Thomas Meyer, Julian Großkreutz,

The Lancet Neurology · 2018 · 80 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Dose-ranging study of riluzole in amyotrophic lateral sclerosis

Lucette Lacomblez, Gilbert Bensimon, Vincent Meininger et al. · The Lancet · 1996 · 1.3K citations

, , +13

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

, , +11

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

C. Warren Olanow, Olivier Rascol, Robert A. Hauser et al. · New England Journal of Medicine · 2009 · 891 citations · Full text

, , +17

A Controlled Trial of Rasagiline in Early Parkinson Disease

Archives of Neurology · 2002 · 583 citations · Full text

, , +16

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study

Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey et al. · The Lancet Neurology · 2018 · 252 citations · Full text

, , +12